Q4 2018 Innovate Biopharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to the Innovate Biopharmaceuticals Corporate and Operational Progress Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Jennifer Zimmons, Investor Relations for Innovate Biopharmaceuticals. Please go ahead, Jennifer.
Thank you, Kevin. Good morning, and thank you for joining us to discuss our recent business progress and Innovate's Full Year 2018 Financial Results and Corporate Highlights Conference Call. The press release containing the company's financial results for 2018 was issued earlier.
Joining our call are Steve Laumas, Chief Executive Officer; Patrick -- and Patrick Griffin, Chief Medical Officer. Jay Madan, Chief Business Officer, will also be joining for the Q&A session.
Before we begin, I'd like to remind everyone that this conference call includes forward-looking statements. Each forward-looking statement contained in this call is subject
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
